Vanda Pharmaceuticals Inc. (VNDA) Financials

VNDA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 433.5 million 152.8 million
Dec. 31, 2025 488.9 million 161.8 million
Sept. 30, 2025 601.1 million 135.1 million
June 30, 2025 624.7 million 138.4 million

VNDA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -50.4 million ?
Dec. 31, 2025 -29.5 million 2.3 million
Sept. 30, 2025 -31.8 million 2.1 million
June 30, 2025 -15.6 million 2.1 million

VNDA Net Income

No data available :(

VNDA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 202.3 million - 7.1 million
Dec. 31, 2025 263.8 million - 12.6 million
Sept. 30, 2025 293.8 million - 10.9 million
June 30, 2025 325.6 million - 11.6 million

VNDA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 59.5 million
Dec. 31, 2025 59.1 million
Sept. 30, 2025 58.9 million
June 30, 2025 59.0 million

VNDA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 221000 28.4 million 68.4 million -
Dec. 31, 2025 102000 29.0 million 63.0 million -
Sept. 30, 2025 161000 22.6 million 60.3 million -
June 30, 2025 299000 22.0 million 64.6 million -

VNDA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 51.7 million 5.1 million
Dec. 31, 2025 57.2 million 3.8 million
Sept. 30, 2025 56.3 million 3.0 million
June 30, 2025 52.6 million 4.5 million

VNDA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

VNDA

Price: $5.73

52 week price:
4.14
9.94

Earnings Per Share: -4.06 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 456204

Ebitda: -1.4 million

Market Capitalization: 366.2 million

Links: